News for Thermo Fisher Scientific Inc. (TMO.MX)

On July 18, 2025, Baird analyst Catherine Schulte issued a new report on Thermo Fisher Scientific (TMO), maintaining an "Outperform" rating for the stock. The r

Analyst Catherine Ramsey Schulte from Baird has adjusted the price target for Thermo Fisher (TMO), reducing it from $573 to $553. Despite this revision, the fir

Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced an expansion of their strategic partnership with Sanofi to enabl

Thermo Fisher Scientific expands its capabilities with an acquisition of Sanofi's facility in Ridgefield, New Jersey. Analysts forecast a significant up

Thermo Fisher Scientific (TMO) expands its strategic partnership with Sanofi by acquiring their Ridgefield, New Jersey manufacturing site. The acquisiti

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of Goldman Sachs’ top healthcare stock picks. On June 25, the company confirmed it had inked a strategic partnership with Adial Pharmaceuticals (NASDAQ:ADIL). Under the terms of the agreement, Thermo Fisher is to become the Contract Development and Manufacturing Organization (CDMO) for AD04 Drug products. The product is […]

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the 13 Best Large Cap Stocks to Buy Right Now. On July 11, Scotiabank upgraded its rating for Thermo Fisher Scientific Inc. (NYSE:TMO) from “Sector Perform” to “Outperform” while also setting a new price target of $590, down from the previous $605. The bank believes that the […]

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

On July 11, 2025, Scotiabank analyst Sung Ji Nam upgraded Thermo Fisher Scientific (TMO) from a 'Sector Perform' rating to a 'Sector Outperform' rating.As part

Thermo Fisher Scientific (TMO) has been upgraded by Scotiabank from a 'Sector Perform' rating to an 'Outperform' status. The bank adjusted its price target for

Scotiabank has elevated its rating for Thermo Fisher (TMO) from Sector Perform to Outperform. The financial institution has set a price target of $590 for the c

SAP gains on cloud strength, NVO faces obesity setbacks, and TMO leans on AI and innovation amid macro headwinds.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Growth Strategy” second quarter 2025 investor letter. A copy of the letter can be downloaded here. In the second quarter, the growth stocks rebounded from tariff uncertainty, with technology and communication services sectors leading in the return to a risk-on environment. The S&P 500 […]

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the 10 Best Dip Stocks to Buy According to Billionaires. On July 3, Thermo Fisher Scientific Inc. (NYSE:TMO) announced receiving FDA approval for its Oncomine Dx Express Test on the Ion Torrent Genexus Dx Integrated Sequencer. After the approval, this test is now authorized as an in vitro diagnostic […]

Tap into America’s resilient healthcare sector with these promising stocks poised to thrive in the second half of 2025

Delray Beach, FL, July 04, 2025 (GLOBE NEWSWIRE) -- In terms of value, the Sodium Perborate Market  is expected to reach USD 184.0 million in 2030 from USD 153.3 million in 2025, registering a CAGR of 3.7%, as per the recent study by MarketsandMarkets™. The demand for sodium perborate is consistently increasing across industries such as healthcare, detergents, and textiles. As a potent bleaching agent and disinfectant, sodium perborate enhances efficacy while aligning with stringent environmental regulations. The industry’s shift toward low-toxicity and high-efficiency formulations is becoming increasingly prominent as production methodologies advance. This transition to sustainable alternatives, characterized by high performance, is a critical factor influencing the market’s future landscape.

Solventum Corporation (NYSE:SOLV) is one of the best new stocks to buy now. On June 25, Solventum announced an amendment to its transaction agreement with Thermo Fisher Scientific Inc. (NYSE:TMO). The revised agreement now excludes Solventum’s drinking water filtration business from the assets being acquired by Thermo Fisher. Consequently, the cash consideration for the acquisition […]

TMO's financials show profitability but lack a clear positive trend, creating ongoing pressure on the stock price and limiting near-term upside. Click to read.